Stock AQP AQUAPORIN A/S
Add to a list
To use this feature you must be a member
Log inSign up

Highlights Aquaporin A/S

Equities

AQP

DK0061555109

Market Closed - Nasdaq Copenhagen
Other stock markets
 08:19:24 13/05/2024 pm IST 		5-day change 1st Jan Change
13.5 DKK +1.50% Intraday chart for Aquaporin A/S -5.26% -70.65%
05/04 Transcript : Aquaporin A/S, 2023 Earnings Call, Apr 05, 2024
05/04 Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Aquaporin A/S Provides Earnings Guidance for the Year 2024
CI
AstraZeneca Says Ultomiris Gets US FDA Approval to Treat Neuromyelitis Optica Spectrum Disorder
MT
AstraZeneca Bags US FDA Clearance for Rare Autoimmune Disease Treatment Ultomiris
MT
Aquaporin A/S Provides Earnings Guidance for the Financial Year 2024
CI
Aquaporin A/S Maintains Earnings Guidance for the Full Year 2023
CI
AstraZeneca's Soliris Approved in China for Treatment of Neuromyelitis Optica Spectrum Disorder
MT
Aquaporin A/S Reaffirms Earnings Guidance for the Year 2023
CI
Aquaporin A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
CI
Aquaporin A/S Provides Earnings Guidance of the Full Year 2023
CI
Correction: AstraZeneca's Rare Inflammatory Disease Drug Wins EU Health Agency's Positive Recommendation
MT
AstraZeneca's Rare Inflammatory Disease Wins EU Health Agency's Positive Recommendation
MT
Aquaporin A/S Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Aquaporin A/S Provides Earnings Guidance for the Year 2023
CI
Aquaporin Partners with Philips Unit for Water Purifier Technology in China
MT
Aquaporin A/S and AquaShield Announce Partnership to Deliver Clean Drinking Water in China
CI
Horizon Therapeutics Says its Uplizna Approved in Brazil for Adults With Neuromyelitis Optica Spectrum Disorders
MT
Aquaporin A/S Provides Earnings Guidance for the Fiscal Year 2022
CI
Aquaporin A/S issues warrants under the existing incentive program and a new program
AQ
Aquaporin A/S Maintains Financial Outlook for Full-Year 2022
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AQP Stock
  4. News Aquaporin A/S
  5. Highlights
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW